126 related articles for article (PubMed ID: 38627967)
1. Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transition.
Lin J; Hou L; Zhao X; Zhong J; Lv Y; Jiang X; Ye B; Qiao Y
Mol Ther; 2024 Jun; 32(6):1956-1969. PubMed ID: 38627967
[TBL] [Abstract][Full Text] [Related]
2. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
3. E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.
Gondkar K; Patel K; Krishnappa S; Patil A; Nair B; Sundaram GM; Zea TT; Kumar P
Cancer Biomark; 2019; 25(2):223-232. PubMed ID: 31104013
[TBL] [Abstract][Full Text] [Related]
4. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X
Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781
[TBL] [Abstract][Full Text] [Related]
5. ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.
Liu D; Skomorovska Y; Song J; Bowler E; Harris R; Ravasz M; Bai S; Ayati M; Tamai K; Koyuturk M; Yuan X; Wang Z; Wang Y; Ewing RM
Cancer Biol Ther; 2019; 20(1):90-100. PubMed ID: 30148686
[No Abstract] [Full Text] [Related]
6. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
[TBL] [Abstract][Full Text] [Related]
7. FZD5 prevents epithelial-mesenchymal transition in gastric cancer.
Dong D; Na L; Zhou K; Wang Z; Sun Y; Zheng Q; Gao J; Zhao C; Wang W
Cell Commun Signal; 2021 Feb; 19(1):21. PubMed ID: 33618713
[TBL] [Abstract][Full Text] [Related]
8. E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer.
Suzuki M; Saito-Adachi M; Arai Y; Fujiwara Y; Takai E; Shibata S; Seki M; Rokutan H; Maeda D; Horie M; Suzuki Y; Shibata T; Kiyono T; Yachida S
Cancer Res; 2021 Jan; 81(2):489-500. PubMed ID: 33293429
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma.
Dong Z; Yang L; Lu J; Guo Y; Shen S; Liang J; Guo W
Clin Exp Metastasis; 2022 Aug; 39(4):661-677. PubMed ID: 35616822
[TBL] [Abstract][Full Text] [Related]
10. The Transcription Factor
Sengez B; Aygün I; Shehwana H; Toyran N; Tercan Avci S; Konu O; Stemmler MP; Alotaibi H
Cells; 2019 Aug; 8(8):. PubMed ID: 31404945
[TBL] [Abstract][Full Text] [Related]
11. Enhancer Reprogramming within Pre-existing Topologically Associated Domains Promotes TGF-β-Induced EMT and Cancer Metastasis.
Qiao Y; Wang Z; Tan F; Chen J; Lin J; Yang J; Li H; Wang X; Sali A; Zhang L; Zhong G
Mol Ther; 2020 Sep; 28(9):2083-2095. PubMed ID: 32526202
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
[TBL] [Abstract][Full Text] [Related]
13. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
[TBL] [Abstract][Full Text] [Related]
14. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
[TBL] [Abstract][Full Text] [Related]
15. TGF-β-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma.
Miyashita N; Enokido T; Horie M; Fukuda K; Urushiyama H; Strell C; Brunnström H; Micke P; Saito A; Nagase T
Sci Rep; 2021 Nov; 11(1):22380. PubMed ID: 34789779
[TBL] [Abstract][Full Text] [Related]
16. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
[TBL] [Abstract][Full Text] [Related]
17. ELF3-AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood.
Song S; He X; Wang J; Wang R; Wang L; Zhao W; Wang Y; Zhang Y; Yu Z; Miao D; Xue Y
Cancer Sci; 2021 Nov; 112(11):4553-4569. PubMed ID: 34418240
[TBL] [Abstract][Full Text] [Related]
18. Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition.
Chang H; Liu Y; Xue M; Liu H; Du S; Zhang L; Wang P
Nucleic Acids Res; 2016 Apr; 44(6):2514-27. PubMed ID: 26926107
[TBL] [Abstract][Full Text] [Related]
19. WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma.
Na L; Wang Z; Bai Y; Sun Y; Dong D; Wang W; Zhao C
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166271. PubMed ID: 34562599
[TBL] [Abstract][Full Text] [Related]
20. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
Yuki R
Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
